BiomX outlines imminent FDA feedback and targets BX004 Phase IIb data in Q1 2026 while advancing BX011 for diabetic foot infections

Q3 2025 Management View Jonathan Solomon, CEO, stated that the third quarter of 2025 was an important period for BiomX, ...
TCTMD

CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI

The drug, delivered by EMS as a single injection, improved infarct-related patency at cath lab arrival and 30-day clinical outcomes.
Medindia

Cereno Scientific Submits Phase IIb Trial Protocol for CS1 in Pulmonary Arterial Hypertension (PAH) to the U.S. FDA

Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced the ...
Clinical Trials Arena on MSN

Imbria randomises first subject in Phase IIb trial of nHCM therapy

I mbria Pharmaceuticals has randomised the first participant in FORTITUDE HCM, a Phase IIb trial of ninerafaxstat in ...

Psyence BioMed Doses Multiple Patients and Expands Clinical Sites in Phase IIb Study for Adjustment Disorder in Palliative Care

The Phase IIb study has been strategically designed to meet regulatory expectations for pivotal clinical evidence. Its larger sample size, rigorous randomization, and multi-site structure enhance ...
BioWorld

Lumosa’s stroke drug meets phase IIb endpoints in China

Lumosa Therapeutics Co. Ltd.’s intravenous odatroltide (LT-3001) met the primary endpoints in a phase IIb trial in China in patients with acute ischemic stroke, paving the way for a pivotal phase III ...
Pharmabiz

Cereno Scientific submits phase IIb trial protocol for CS1 in pulmonary arterial hypertension to US FDA

Gothenburg, Sweden Tuesday, November 11, 2025, 15:00 Hrs [IST] ...